semaglutide drugs Comparing Ozempic, Wegovy and Other GLP-1 FDA warns about compounded versions

Can chewing-based probiotics influence appetite control

But retatrutide (LY3437943) backed up the hype with numbers no obesity drug has matched: 24.2% average body weight reduction at the highest dose in just 48 weeks, published in the *New England Journal of Medicine* by Jastreboff et al

Supplementary analyses A larger proportion of the patients initiating metformin died compared to patients initiating GLP1 RA, 16 and 5, respectively

You may think that losing weight would naturally make it easier to get up, move around and exercise morebut new research suggests that may not be the case for people taking popular weight-loss drugs

Decreased GLP-1 levels are part of this human adaptive response to weight loss

This content should not be taken as legal advice from an attorney